I. MacIntyre

17.6k total citations · 1 hit paper
245 papers, 13.6k citations indexed

About

I. MacIntyre is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, I. MacIntyre has authored 245 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 77 papers in Cellular and Molecular Neuroscience and 43 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in I. MacIntyre's work include Neuropeptides and Animal Physiology (77 papers), Hormonal Regulation and Hypertension (24 papers) and Receptor Mechanisms and Signaling (23 papers). I. MacIntyre is often cited by papers focused on Neuropeptides and Animal Physiology (77 papers), Hormonal Regulation and Hypertension (24 papers) and Receptor Mechanisms and Signaling (23 papers). I. MacIntyre collaborates with scholars based in United Kingdom, Japan and United States. I. MacIntyre's co-authors include Howard R. Morris, John R. Tippins, Samia I. Girgis, Susan D. Brain, Mone Zaidi, T.J. Williams, C. J. Hillyard, P.C. Emson, M. Tohyama and Sunil J. Wimalawansa and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

I. MacIntyre

238 papers receiving 12.7k citations

Hit Papers

Calcitonin gene-related peptide is a potent vasodilator 1985 2026 1998 2012 1985 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. MacIntyre United Kingdom 62 6.3k 4.9k 2.7k 2.3k 1.9k 245 13.6k
Hiroo Imura Japan 74 4.3k 0.7× 7.5k 1.5× 3.2k 1.2× 6.6k 2.8× 3.3k 1.7× 755 24.4k
Howard Rasmussen United States 60 1.5k 0.2× 6.3k 1.3× 2.3k 0.9× 1.9k 0.8× 1.6k 0.8× 224 12.5k
Fumiaki Marumo Japan 89 2.3k 0.4× 13.4k 2.7× 6.4k 2.4× 2.1k 0.9× 2.5k 1.3× 626 28.0k
P. James B. Dyck United States 81 7.0k 1.1× 4.1k 0.8× 7.4k 2.8× 2.2k 0.9× 2.4k 1.2× 438 23.4k
Mone Zaidi United States 63 1.6k 0.3× 7.2k 1.5× 1.9k 0.7× 2.5k 1.1× 1.2k 0.6× 308 14.0k
Susan D. Brain United Kingdom 59 5.4k 0.9× 3.9k 0.8× 4.5k 1.7× 805 0.3× 1.6k 0.8× 246 13.9k
Steven Hébert United States 64 2.0k 0.3× 9.2k 1.9× 1.6k 0.6× 1.1k 0.5× 1.2k 0.6× 175 14.1k
Donald D. Heistad United States 85 2.3k 0.4× 5.1k 1.0× 7.8k 2.9× 1.4k 0.6× 3.6k 1.9× 460 25.5k
Akiyoshi Fukamizu Japan 75 1.4k 0.2× 10.8k 2.2× 2.3k 0.8× 3.1k 1.3× 2.4k 1.3× 365 20.9k
R. Håkanson Sweden 81 13.1k 2.1× 9.8k 2.0× 4.2k 1.6× 2.5k 1.1× 7.7k 4.0× 545 24.5k

Countries citing papers authored by I. MacIntyre

Since Specialization
Citations

This map shows the geographic impact of I. MacIntyre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. MacIntyre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. MacIntyre more than expected).

Fields of papers citing papers by I. MacIntyre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. MacIntyre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. MacIntyre. The network helps show where I. MacIntyre may publish in the future.

Co-authorship network of co-authors of I. MacIntyre

This figure shows the co-authorship network connecting the top 25 collaborators of I. MacIntyre. A scholar is included among the top collaborators of I. MacIntyre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. MacIntyre. I. MacIntyre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MacIntyre, I., Sian Sloan‐Dennison, Benjamin Clark, et al.. (2024). Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). Toxicological Sciences. 199(2). 203–209. 1 indexed citations
2.
Faconti, Luca, Sarah Partridge, Christian Delles, et al.. (2024). Investigation and management of young-onset hypertension: British and Irish hypertension society position statement. Journal of Human Hypertension. 38(7). 544–554. 2 indexed citations
3.
MacIntyre, I., Emma Turtle, Tariq E. Farrah, et al.. (2022). Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial. Circulation. 145(6). 416–423. 30 indexed citations
4.
McCallum, Linsay, Katriona Brooksbank, Alex McConnachie, et al.. (2020). Rationale and Design of the Genotype-Blinded Trial of Torasemide for the Treatment of Hypertension (BHF UMOD). American Journal of Hypertension. 34(1). 92–99. 11 indexed citations
5.
Benesch, Matthew G.K., I. MacIntyre, Todd McMullen, & David N. Brindley. (2018). Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation. Cancers. 10(3). 73–73. 58 indexed citations
6.
MacIntyre, I., Neeraj Dhaun, Pajaree Lilitkarntakul, et al.. (2010). Greater Functional ET B Receptor Antagonism With Bosentan Than Sitaxsentan in Healthy Men. Hypertension. 55(6). 1406–1411. 12 indexed citations
7.
Dhaun, Neeraj, I. MacIntyre, Vanessa Melville, et al.. (2009). Blood Pressure–Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease. Hypertension. 54(1). 113–119. 101 indexed citations
8.
Zaidi, Mone, Baljit S. Moonga, Peter J.R. Bevis, et al.. (1991). Expression and Function of the Calcitonin Gene Products. Vitamins and hormones. 46. 87–164. 19 indexed citations
9.
MacIntyre, I., et al.. (1990). Biological activity of calcitonin and its assessment. Experimental Gerontology. 25(3-4). 331–338. 2 indexed citations
10.
Tippins, John R., Stephen E. Greenwald, M. J. Lever, I. MacIntyre, & Howard R. Morris. (1989). Coronary vasodilation induced by calcitonin gene-related peptide in the anaesthetised pig. Neuropeptides. 13(2). 95–102. 1 indexed citations
11.
Zaidi, Mone, Baljit S. Moonga, Donald Moss, & I. MacIntyre. (1989). Inhibition of osteoclastic acid phosphatase abolishes bone resorption. Biochemical and Biophysical Research Communications. 159(1). 68–71. 85 indexed citations
12.
Eisman, J. A., I. MacIntyre, David M. Findlay, et al.. (1980). Calcitonin and 1,25-dihydroxycholecalciferol receptors in human breast cancer cells. Journal of Endocrinology. 87(2). 2 indexed citations
13.
Brown, Dennis, E. Spanos, & I. MacIntyre. (1980). Role of pituitary hormones in regulating renal vitamin D metabolism in man.. BMJ. 280(6210). 277–278. 47 indexed citations
14.
Brown, Drew M., et al.. (1978). Regulation of 25-hydroxycholecalciferol metabolism by 1,25-dihydroxycholecalciferol in relation to phosphate concentrations [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 79(2). 35P–36P. 1 indexed citations
15.
Krook, L, et al.. (1977). Calcitonin and hibernation bone loss in the bat (Myotis lucifugus).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 67(2). 265–71. 12 indexed citations
16.
Bouchier, I. A. D., et al.. (1969). University Clinical Teachers' Pay. BMJ. 1(5645). 717.3–717. 1 indexed citations
17.
Robinson, C. J., T. John Martin, & I. MacIntyre. (1966). PHOSPHATURIC EFFECT OF THYROCALCITONIN. The Lancet. 288(7454). 83–84. 34 indexed citations
18.
Martin, T. John, C. J. Robinson, & I. MacIntyre. (1966). THE MODE OF ACTION OF THYROCALCITONIN. The Lancet. 287(7443). 900–902. 73 indexed citations
19.
Kumar, M. Ashwini, Giraud V. Foster, & I. MacIntyre. (1963). FURTHER EVIDENCE FOR CALCITONIN A RAPID-ACTING HORMONE WHICH LOWERS PLASMA-CALCIUM. The Lancet. 282(7306). 480–482. 85 indexed citations
20.
Hanna, S. & I. MacIntyre. (1960). THE INFLUENCE OF ALDOSTERONE ON MAGNESIUM METABOLISM. The Lancet. 276(7146). 348–350. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026